Relationship between time to trastuzumab initiation and overall survival among young commercially insured women with metastatic breast cancer

被引:0
|
作者
Leopold, Christine
Zhang, Fang
Wagner, Anita K.
Lu, Christine Y.
Earle, Craig
Ross-Degnan, Dennis
Wharam, James Frank
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Harvard Pilgrim Inst, Dept Populat Med, Drug Policy Res Grp, Boston, MA USA
[3] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA
[4] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
[5] Ontario Inst Canc Res, Toronto, ON, Canada
关键词
D O I
10.1200/JCO.2016.34.15_suppl.e18013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18013
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Obesity and breast cancer survival among young women.
    Abrahamson, PE
    Gammon, MD
    Lund, MJ
    Eley, W
    Flagg, EW
    Porter, P
    Brinton, LA
    Coates, RJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S38 - S38
  • [32] Evaluating disparities in receptor status, overall survival, and time to hormone therapy among women with breast cancer
    Taparra, Kekoa A.
    DeVille, Nicole V.
    Melendez-Ramos, Alex
    Blanco-Portillo, Javier
    Ioannidis, Alexander
    Patel, Manali I.
    Pollom, Erqi L.
    Horst, Kathleen C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Association between bisphosphonate use in metastatic breast cancer (MBC) and overall survival
    Mathew, A.
    Rosenzweig, M. Q.
    Brufsky, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [34] Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
    Gobbini, Elisa
    Ezzalfani, Monia
    Dieras, Veronique
    Bachelot, Thomas
    Brain, Etienne
    Debled, Marc
    Jacot, William
    Mouret-Reynier, Marie Ange
    Goncalves, Anthony
    Dalenc, Florence
    Patsouris, Anne
    Ferrero, Jean Marc
    Levy, Christelle
    Lorgis, Veronique
    Vanlemmens, Laurence
    Lefeuvre-Plesse, Claudia
    Mathoulin-Pelissier, Simone
    Petit, Thierry
    Uwer, Lionel
    Jouannaud, Christelle
    Leheurteur, Marianne
    Lacroix-Triki, Magali
    Cleaud, Audrey Lardy
    Robain, Mathieu
    Courtinard, Coralie
    Cailliot, Christian
    Perol, David
    Delaloge, Suzette
    EUROPEAN JOURNAL OF CANCER, 2018, 96 : 17 - 24
  • [35] Differences in survival among women with primary and secondary metastatic breast cancer
    Barinoff, J.
    Schmidt, M.
    Schneeweiss, A.
    Hinke, A.
    Schoenegg, W.
    Henken, S.
    Kutscheidt, A.
    Pintoffl, J.
    Jackisch, C.
    CANCER RESEARCH, 2013, 73
  • [36] Sleep, diurnal cortisol, and survival among women with metastatic breast cancer
    Spiegel, David
    Hahm, Bong-Jim
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2012, 3
  • [37] The Influence of Comorbidities on Overall Survival Among Older Women Diagnosed With Breast Cancer
    Patnaik, Jennifer L.
    Byers, Tim
    DiGuiseppi, Carolyn
    Denberg, Thomas D.
    Dabelea, Dana
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (14): : 1101 - 1111
  • [38] MEASURES OF NEIGHBORHOOD STRUCTURAL RACISM AND OVERALL SURVIVAL AMONG PATIENTS WITH METASTATIC BREAST CANCER
    Pittell, H.
    Calip, G.
    Pierre, A.
    Ryals, C.
    Guadamuz, J.
    VALUE IN HEALTH, 2023, 26 (06) : S2 - S2
  • [39] The relationship between age and survival outcomes for eribulin in metastatic breast cancer
    Twelves, C.
    Vahdat, L. T.
    Cortes, J.
    Wanders, J.
    Dutcus, C. E.
    Seegobin, S.
    Muss, H. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Visualization of the relationship between survival and sequential treatments in metastatic breast cancer
    Rocque, Gabrielle
    Gilbert, Aidan
    Williams, Courtney P.
    Nakhmani, Arie
    Kandhare, Pravinkumar G.
    Azuero, Andres
    Bhatia, Smita
    Kenzik, Kelly M.
    Burkard, Mark E.
    CANCER RESEARCH, 2020, 80 (04)